Background: Clinically, the patients with significant WBC decrease are mostly administered G-CSF, this kind of drugs
Note: Compared with group B, the death rate of each group has no significant difference (P>0.05).
The reason for the number of death recorded in group E and H mice was due to stomach filling; while that of group B and D may be that WBC was too low; hence resistance was low; the cause for group A and C is not clear; the mice in group F and G were alive. Compared with group B, the death rate of each group has no significant difference (P>0.05). Clinically, the patients with significant WBC decrease are mostly administered G-CSF, rhG-CSF injection (G-CSF)
Influence of different oral Leucocyte increasing drugs to blood three lines of mice (
has more positive treatment effect, but expensive and efficacy is short-term, so it is not suitable for long-term use, the common complications include: fever, rash, muscle and joint pain and other adverse reactions. In which, muscle and joint pain often make the patients difficult to tolerate, seriously affects life quality of patients with malignant tumor during the treatment. At the same time, repeated injection of G-CSF can also cause dysfunction of bone marrow hematopoietic system, promote and induce myelodysplastic syndrome and acute myeloid leukemia, etc. If chemotherapy causes damage to bone marrow hematopoietic stem cell and lack of raw materials to general blood cells, or causes bone marrow reserve capacity of elderly patients is low, it is difficult to generate granulocytes if solely relying on G-CSF. In contrast, oral Leucocyte increasing drug has small adverse reactions, can be used for longer time and can improve the continuity and stability of treatment. However, the effect of WBC increasing is often not obvious if solely using oral drug, the combination of G-CSF and peroal Leucocyte increasing drug can make up with each other to get better effect. Therefore, clinically, it is more to combine injection with oral drugs to treat leucopenia or deficiency after chemotherapy. However, there is no uniform standard on how to combine these drugs, different hospitals have their own combination habits and cannot be unified. Some patients go to doctors of different hospitals in different stages of chemotherapy, but the prescriptions are various and different, even in order to treat the same degree of leucopenia or deficiency. The patients inadvertently become 'drug jar' and 'experimental product', and such unsystematic phenomenon seriously affected normative treatment and increased the probability of complications.
Therefore, it is necessary to regulate drug combination of these patients.
The peroal Leucocyte increasing drugs involved in this study are commonly used in clinic, the main components This study attempts to compare the five drugs' effect through animal experiments. CTX is one of commonly used chemotherapy drugs in clinic and CTX injection in abdominal cavity of mice is chemotherapy-related leucopenia model preparation method commonly used in the clinic. This study makes rhG-CSF as treatment group positive control, it can increase total WBC number through enhancing the number of neutrophils, so there is increase of percentage of neutrophils and lymphocyte percentage is decreased relatively. Generally, chemotherapy drugs have inhibitory effect to blood three lines. This experiment proves that, after injecting CTX in abdominal cavity, the WBC, RBC, platelet and This study hopes to update the knowledge of clinicians to these drugs through experimental study, to help more standardized and flexible use in the clinic. However, the differences between people and animals may lead to different reactions to drugs, so the results still need further clinical study to validate.
Ethical approval
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The Committee on the Ethics of Animal Experiments of Zhejiang Cancer Hospital was secured for our research reported. Zhejiang Cancer Institutional Animal Care and Use Committee (IACUC) specifically approved this study. All authors abided the related rules of Committee on the Ethics of Animal Experiments of Zhejiang Cancer Hospital when this study began. All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering.
